Eric Tu
- Immunology top 5%
- Immune Cell Function and Interaction 7
- IL-33, ST2, and ILC Pathways 4
- T-cell and B-cell Immunology 3
- Oncology top 10%
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 4
- Periodontics top 5%
- Physiology top 10%
-
- NF-κB Signaling Pathways 4
-
- Virus-based gene therapy research 2
-
- Helicobacter pylori-related gastroenterology studies 2
- Co-authors
- Wanjun ChenDunfang ZhangRuiqing WuMei DongYun ZhangKai ZhangXiao MengJianmin Yang
- Cited by
- ImmunologyOncologyPeriodontics
- Partner nations
- United StatesChinaJapan
In The Last Decade
Eric Tu
19 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 90
- Immunology 549
- Oncology 246
- Periodontics 41
- Physiology 36
- Biological Psychiatry 16
Countries citing papers authored by Eric Tu
This map shows the geographic impact of Eric Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Tu more than expected).
Fields of papers citing papers by Eric Tu
This network shows the impact of papers produced by Eric Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Tu. The network helps show where Eric Tu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 27 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 75 | |
| 7 | 2022 | 1 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 208 | |
| 10 | 2019 | 42 | |
| 11 | 2018 | 63 | |
| 12 | 2015 | 306 | |
| 13 | 2015 | 69 | |
| 14 | 2015 | 34 | |
| 15 | 2014 | 115 | |
| 16 | 2014 | 51 | |
| 17 | 2013 | 10 | |
| 18 | 2013 | 33 | |
| 19 | 2012 | 24 | |
| 20 | 2011 | 3 |
About Eric Tu
Eric Tu is a scholar working on Immunology, Biological Psychiatry and Oncology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (6 papers), IL-33, ST2, and ILC Pathways (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), NF-κB Signaling Pathways (4 papers), T-cell and B-cell Immunology (3 papers), Virus-based gene therapy research (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Immunology (549 citations), Oncology (246 citations) and Periodontics (41 citations). Eric Tu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Wanjun Chen, Dunfang Zhang, Ruiqing Wu, Wanjun Chen, Mei Dong, Yun Zhang, Kai Zhang, Xiao Meng, Jianmin Yang and Cheng Zhang. Their work appears in journals such as Cancer Research, Immunity, European Journal of Immunology, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.